ERS Genomics and KU Leuven Sign CRISPR/Cas9 License Agreement to Expand CRISPR-Enabled Research Services
Agreement gives KU Leuven's Leuven Viral Vector Core access to foundational CRISPR/Cas9 intellectual property, supporting genome editing services for academic and industry researchers worldwide DUBLIN, and LEUVEN, Belgium, Oct. 22, 2026 /PRNewswire/ -- ERS Genomics Limited ('ERS...
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


